Septal Solutions
Developer of minimally invasive transcatheter solutions for structural heart disease, focused on a catheter-based septal myotomy to treat obstructive hypertrophic cardiomyopathy. The organization combines medical-device engineering, product development, and clinical collaboration to create a transfemoral, procedure-oriented device intended to reduce left ventricular outflow tract obstruction. The company is in a development stage; its myotomy solution is not approved by the FDA.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Transcatheter septal myotomy solution
A development-stage transfemoral catheter system designed to perform controlled laceration of a hypertrophied interventricular septum to relieve left ventricular outflow tract obstruction. The device emphasizes orientation, securing, and controlled actuation to enable repeatable procedures. Not approved by the FDA.
Transcatheter septal myotomy solution
A development-stage transfemoral catheter system designed to perform controlled laceration of a hypertrophied interventricular septum to relieve left ventricular outflow tract obstruction. The device emphasizes orientation, securing, and controlled actuation to enable repeatable procedures. Not approved by the FDA.
Expertise Areas
- Structural heart device development
- Transcatheter intervention design
- Medical device engineering and design
- Interventional cardiology procedure development
Key Technologies
- Transfemoral catheter access
- Catheter-based tissue laceration for septal myotomy
- Minimally invasive transcatheter device platforms
- Procedure orientation and securing mechanisms